Shields Health Solutions has partnered with US-based health system Duke Health to expand speciality pharmacy services.

The collaboration is set to advance clinical care and improve health outcomes in North Carolina through the Duke Specialty Pharmacy expansion.

This initiative is built to support patients by reducing costs, offering broader treatment options, and improving medication management.

Patients using Duke Specialty Pharmacy will benefit from personalised, patient-centred care. This includes enhanced access to financial guidance, improved medication adherence, medication delivery, regular follow-ups, and side effect management.

Shields' broad reach into payer networks and the range of drugs on offer will afford patients options in their specialist pharmacy care, enabling them to make use of services via Duke Specialty Pharmacy.

The programme will introduce broadened support services, centred on caring for patients with intricate long-term health issues.

In addition, the endeavour seeks to encompass a wider array of patient groups going forward, improving the accessibility of healthcare.

Shields Health Solutions CEO Michael Ham said: “Our partnership with Duke Health underscores the health system’s unwavering commitment to providing superior patient care and differentiated patient experiences.

“We look forward to working alongside Duke Health as it expands its speciality pharmacy services and its impact on complex patients in the Greater Raleigh–Durham community.”

Shields Health Solutions currently collaborates with approximately 80 health systems nationwide, assisting patients in lessening co-pays and receiving medication promptly.

In October 2024, Shields Health Solutions announced a collaboration with Sutter Health to enhance speciality medications accessibility for US patients with chronic, rare, and complex conditions.